Medical Imaging Corporation (TPEX:6637)
Taiwan
· Delayed Price · Currency is TWD 76.30
+0.20 (0.26%)
May 15, 2025, 1:23 PM CST
Medical Imaging Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 782.99 | 829.03 | 682.18 | 487.29 | 604.12 | 545.92 | Upgrade
|
| Revenue Growth (YoY) | 8.55% | 21.52% | 40.00% | -19.34% | 10.66% | 8.04% | Upgrade
|
| Cost of Revenue | 470.1 | 492.93 | 353.86 | 247.79 | 377.02 | 326.4 | Upgrade
|
| Gross Profit | 312.89 | 336.09 | 328.32 | 239.51 | 227.1 | 219.51 | Upgrade
|
| Selling, General & Admin | 134.08 | 136.46 | 116.41 | 93.06 | 92.23 | 90.48 | Upgrade
|
| Operating Expenses | 134.03 | 136.42 | 116.66 | 93.11 | 92.36 | 90.46 | Upgrade
|
| Operating Income | 178.86 | 199.67 | 211.66 | 146.4 | 134.75 | 129.05 | Upgrade
|
| Interest Expense | -3.39 | -2.64 | -2.78 | -3.38 | -3.69 | -3.43 | Upgrade
|
| Interest & Investment Income | 5.92 | 5.24 | 2.13 | 2.18 | 2.8 | 3.72 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 6.66 | -30.71 | -9.19 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.48 | 0.48 | -0.01 | 1.66 | -0.08 | -1.73 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.64 | -0.72 | -0.2 | -0.12 | -0.95 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | 184.51 | 202.04 | 210.8 | 153.39 | 102.12 | 118.35 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.99 | -1.99 | -43.06 | -10.12 | -5.68 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 8.33 | 8.33 | 0.75 | 1.24 | 1.65 | 1.71 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 3.06 | Upgrade
|
| Pretax Income | 190.75 | 208.38 | 168.49 | 144.5 | 98.09 | 123.12 | Upgrade
|
| Income Tax Expense | 38.72 | 43.36 | 47.15 | 32.9 | 21.32 | 27.06 | Upgrade
|
| Net Income | 152.03 | 165.02 | 121.34 | 111.6 | 76.78 | 96.06 | Upgrade
|
| Net Income to Common | 152.03 | 165.02 | 121.34 | 111.6 | 76.78 | 96.06 | Upgrade
|
| Net Income Growth | 16.93% | 36.00% | 8.72% | 45.36% | -20.07% | -3.74% | Upgrade
|
| Shares Outstanding (Basic) | 24 | 23 | 21 | 21 | 21 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 23 | 22 | 22 | 22 | 21 | Upgrade
|
| Shares Change (YoY) | 10.72% | 7.38% | -0.07% | -0.01% | 0.12% | -0.10% | Upgrade
|
| EPS (Basic) | 6.41 | 7.17 | 5.66 | 5.20 | 3.58 | 4.48 | Upgrade
|
| EPS (Diluted) | 6.39 | 7.15 | 5.64 | 5.19 | 3.57 | 4.46 | Upgrade
|
| EPS Growth | 5.73% | 26.77% | 8.67% | 45.38% | -19.96% | -3.88% | Upgrade
|
| Free Cash Flow | -135.16 | 172.14 | 88.64 | 211.02 | 81.99 | 70.85 | Upgrade
|
| Free Cash Flow Per Share | -5.67 | 7.46 | 4.12 | 9.80 | 3.81 | 3.30 | Upgrade
|
| Dividend Per Share | - | 4.000 | 3.000 | 2.800 | 2.000 | 2.500 | Upgrade
|
| Dividend Growth | - | 33.33% | 7.14% | 40.00% | -20.00% | - | Upgrade
|
| Gross Margin | 39.96% | 40.54% | 48.13% | 49.15% | 37.59% | 40.21% | Upgrade
|
| Operating Margin | 22.84% | 24.09% | 31.03% | 30.04% | 22.30% | 23.64% | Upgrade
|
| Profit Margin | 19.42% | 19.91% | 17.79% | 22.90% | 12.71% | 17.60% | Upgrade
|
| Free Cash Flow Margin | -17.26% | 20.76% | 12.99% | 43.30% | 13.57% | 12.98% | Upgrade
|
| EBITDA | 228.42 | 248.76 | 252.56 | 197.45 | 188.89 | 178.06 | Upgrade
|
| EBITDA Margin | 29.17% | 30.01% | 37.02% | 40.52% | 31.27% | 32.62% | Upgrade
|
| D&A For EBITDA | 49.56 | 49.09 | 40.9 | 51.05 | 54.15 | 49.01 | Upgrade
|
| EBIT | 178.86 | 199.67 | 211.66 | 146.4 | 134.75 | 129.05 | Upgrade
|
| EBIT Margin | 22.84% | 24.09% | 31.03% | 30.04% | 22.30% | 23.64% | Upgrade
|
| Effective Tax Rate | 20.30% | 20.81% | 27.98% | 22.77% | 21.73% | 21.98% | Upgrade
|
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.